American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

作者：Saag Kenneth G; Teng Gim Gee; Patkar Nivedita M; Anuntiyo Jeremy; Finney Catherine; Curtis Jeffrey R; Paulus Harold E; Mudano Amy; Pisu Maria; Elkins Melton Mary; Outman Ryan; Allison Jeroan J; Almazor Maria Suarez; Bridges S Louis Jr; Chatham W Winn; Hochberg Marc; Maclean Catherine; Mikuls Ted; Moreland Larry W; O'Dell James; Turkiewicz Anthony M; Furst Daniel E^*

来源：Arthritis and Rheumatism, 2008, 59(6): 762-784.

DOI：10.1002/art.23721

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.

• 出版日期2008-6-15